Evidence map›Paper›PMID 33072223›Full record

ArticleCellular and molecular bioengineering2014

Network Modeling Approach to Predict Myofibroblast Differentiation.

Alison K Schroer, Larisa M Ryzhova, W David Merryman

Abstract read
In one paragraph

Article in Cellular and molecular bioengineering, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Network modeling predicts personalized gene expression and drug responses in valve myofibroblasts cultured with patient sera.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Computational modeling of cardiac fibroblasts and fibrosis.Journal of molecular and cellular cardiology · 2016
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alison K SchroerDepartment of Biomedical Engineering, Vanderbilt University, Room 9445D, MRB4 2213 Garland Ave, Nashville, TN 37232, USA.
Larisa M RyzhovaDepartment of Biomedical Engineering, Vanderbilt University, Room 9445D, MRB4 2213 Garland Ave, Nashville, TN 37232, USA.
W David MerrymanDepartment of Biomedical Engineering, Vanderbilt University, Room 9445D, MRB4 2213 Garland Ave, Nashville, TN 37232, USA.

Funding

Serotonergic Receptor Targeted Therapy for Degenerative Aortic Valve DiseaseR01HL115103 · NHLBI · VANDERBILT UNIVERSITY · PI MERRYMAN, WILLIAM D · 2013 to 2016
$1.5M
TGF-beta1 activity in the aortic valveK25HL094707 · NHLBI · VANDERBILT UNIVERSITY · PI MERRYMAN, WILLIAM D · 2009 to 2013
$725k
NHLBI NIH HHS K25 HL094707NHLBI NIH HHS R01 HL115103
6 · The paper itself

Abstract

Fibrotic disease is a major cause of morbidity and mortality and is characterized by the transition of resident fibroblast cells into active myofibroblasts, identified by their expression of alpha smooth muscle actin. Myofibroblast differentiation is regulated by growth factor signaling and mechanical signals transduced through integrins, which converge at focal adhesion proteins (Src and FAK) and MAPK signaling, but lead to divergent outcomes. While details are known about individual pathways, little is known about their interactions. To this end, an ODE-based model of this cell signaling network was developed in parallel with

Indexed as

Alpha-smooth muscle actin (αSMA)Extracellular signaling-related kinase (ERK)Fibroblast growth factor (FGF)Focal adhesion kinase (FAK)Integrinp38SrcTransforming growth factor beta (TGF-β1)

Identifiers

PMID33072223
PMCPMC7560994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.